Instil Bio is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. Instil seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need.
| Website | http://instilbio.com |
| Revenue | $56 million |
| Employees | 52 (42 on RocketReach) |
| Founded | 2018 |
| Technologies |
JavaScript
,
HTML
,
PHP
+32 more
(view full list)
|
| Industry | Biotechnology |
| Keywords | Biopharmaceutical, Clinical Stage, Drug Development, Therapeutics, Novel Therapies, Pipeline Development, Unmet Medical Needs, Pharmaceutical Research, Biotechnology, In Licensing, Acquisitions, Therapeutic Candidates, Drug Discovery, Clinical Trials, Research And Development, Life Sciences, Biotech, Medicine, Healthcare, Pharmaceutical |
| Competitors | Novartis, Bristol Myers Squibb, Gilead Sciences, Kite Pharma, bluebird bio, Adaptimmune, Sangamo Therapeutics, Inc., Precigen, Celyad Oncology, TCR² Therapeutics Inc. +31 more (view full list) |
Looking for a particular Instil Bio employee's phone or email?
The Instil Bio annual revenue was $56 million in 2026.
Bronson Crouch is the Chairman and CEO of Instil Bio.
42 people are employed at Instil Bio.